Andrea Cavallini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrea Cavallini has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Sandro Carrara
Laboratory of Integrated Systems, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland
14 shared publicationsGiovanni De Micheli
Laboratory of Integrated Systems, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland
12 shared publications- Giovanni De Micheli
EPFL, Lausanne, Switzerland
8 shared publications - Sandro Carrara
École Polytechnique Fédérale de Lausanne
6 shared publications - Fabio Grassi
Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona 6500, Switzerland
5 shared publications - Luca Benini
University of Bologna, Bologna, Italy
4 shared publications
Latest Publications
- 13 September 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Circuits and Systems
- Vol. 10 (5) , 955-962
In-Vivo Validation of Fully Implantable Multi-Panel Devices for Remote Monitoring of Metabolism
This paper presents the in-vivo tests on a Fully Implantable Multi-Panel Devices for Remote Monitoring of endogenous and exogenous analytes. To investigate issues on biocompatibility, three different covers have been designed, realized and tested in mice for 30 days. ATP and neutrophil concentrations have been measured, at the implant site after the device was explanted, to assess the level of biocompatibility of the device. Finally, fully working prototypes of the device were implanted in mice and tested. The implanted devices were used to detect variations in the physiological concentrations of glucose and paracetamol. Data trends on these analytes have been successfully acquired and transmitted to the external base station. Glucose and paracetamol (also named acetaminophen) have been proposed in this research as model molecules for applications to personalized and translational medicine.
- 13 September 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Circuits and Systems
- Vol. 10 (5) , 955-962
In-Vivo Validation of Fully Implantable Multi-Panel Devices for Remote Monitoring of Metabolism
This paper presents the in-vivo tests on a Fully Implantable Multi-Panel Devices for Remote Monitoring of endogenous and exogenous analytes. To investigate issues on biocompatibility, three different covers have been designed, realized and tested in mice for 30 days. ATP and neutrophil concentrations have been measured, at the implant site after the device was explanted, to assess the level of biocompatibility of the device. Finally, fully working prototypes of the device were implanted in mice and tested. The implanted devices were used to detect variations in the physiological concentrations of glucose and paracetamol. Data trends on these analytes have been successfully acquired and transmitted to the external base station. Glucose and paracetamol (also named acetaminophen) have been proposed in this research as model molecules for applications to personalized and translational medicine.
- 1 October 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Biocompatible packagings for fully implantable multi-panel devices for remote monitoring of metabolism
This paper compares three different biocompatible packaging covers suitable to support full implantation of multi-panel sensors for remote monitoring of metabolism. The three covers have been designed, realized and implanted in mice for 30 days. ATP and neutrophil concentrations have been measured at the implant site after the device was explanted, to assess the level of biocompatibility of the device.
- 1 October 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Biocompatible packagings for fully implantable multi-panel devices for remote monitoring of metabolism
This paper compares three different biocompatible packaging covers suitable to support full implantation of multi-panel sensors for remote monitoring of metabolism. The three covers have been designed, realized and implanted in mice for 30 days. ATP and neutrophil concentrations have been measured at the implant site after the device was explanted, to assess the level of biocompatibility of the device.
- 28 February 2015
- Published by Cambridge University Press (CUP)
- p. 109-121
CNT and proteins for bioelectronics in personalized medicine
From their discovery, CNTs have increasingly attracted interest because of their peculiar electrical, mechanical, and chemical properties. In 1991, Sumio Iijima first observed and described in detail the atomic arrangement of this new type of carbon structure [1]. By a technique used for fullerene synthesis, he produced needle-like tubes at the cathode of an arc-discharge evaporator. From that time, carbon nanotubes have been used for many applications and represent one of the most typical building blocks used in nanotechnology. Their peculiarities include unique properties of field emission and electronic transport, higher mechanical strength with respect to other materials, and interesting chemical features. The use of CNTs has recently gained momentum in the development of electrochemical biosensors, since their utilization can create devices with enhanced sensitivity and detection limit capable of detecting compounds in concentrations comparable to those present in the human body. This chapter will review the most important features of carbon nanotubes, and present an example in which their application can enhance the detection of drugs and metabolites relevant in personalized medicine: P450 biosensors for therapeutic drug monitoring. Overview Carbon is a very interesting element, since it can assume several stable molecular structures. Any molecule entirely composed of carbon is called a fullerene.
- 28 February 2015
- Published by Cambridge University Press (CUP)
- p. 109-121
CNT and proteins for bioelectronics in personalized medicine
From their discovery, CNTs have increasingly attracted interest because of their peculiar electrical, mechanical, and chemical properties. In 1991, Sumio Iijima first observed and described in detail the atomic arrangement of this new type of carbon structure [1]. By a technique used for fullerene synthesis, he produced needle-like tubes at the cathode of an arc-discharge evaporator. From that time, carbon nanotubes have been used for many applications and represent one of the most typical building blocks used in nanotechnology. Their peculiarities include unique properties of field emission and electronic transport, higher mechanical strength with respect to other materials, and interesting chemical features. The use of CNTs has recently gained momentum in the development of electrochemical biosensors, since their utilization can create devices with enhanced sensitivity and detection limit capable of detecting compounds in concentrations comparable to those present in the human body. This chapter will review the most important features of carbon nanotubes, and present an example in which their application can enhance the detection of drugs and metabolites relevant in personalized medicine: P450 biosensors for therapeutic drug monitoring. Overview Carbon is a very interesting element, since it can assume several stable molecular structures. Any molecule entirely composed of carbon is called a fullerene.
- 16 June 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Circuits and Systems
- Vol. 8 (6) , 891-898
An Integrated Control and Readout Circuit for Implantable Multi-Target Electrochemical Biosensing
We describe an integrated biosensor capable of sensing multiple molecular targets using both cyclic voltammetry (CV) and chronoamperometry (CA). In particular, we present our custom IC to realize voltage control and current readout of the biosensors. A mixed-signal circuit block generates sub-Hertz triangular waveform for the biosensors by means of a direct-digital-synthesizer to control CV. A current to pulse-width converter is realized to output the data for CA measurement. The IC is fabricated in 0.18 μm technology. It consumes 220 μW from 1.8 V supply voltage, making it suitable for remotely-powered applications. Electrical measurements show excellent linearity in sub- μA current range. Electrochemical measurements including CA measurements of glucose and lactate and CV measurements of the anti-cancer drug Etoposide have been acquired with the fabricated IC and compared with a commercial equipment. The results obtained with the fabricated IC are in good agreement with those of the commercial equipment for both CV and CA measurements.
- 16 June 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Circuits and Systems
- Vol. 8 (6) , 891-898
An Integrated Control and Readout Circuit for Implantable Multi-Target Electrochemical Biosensing
We describe an integrated biosensor capable of sensing multiple molecular targets using both cyclic voltammetry (CV) and chronoamperometry (CA). In particular, we present our custom IC to realize voltage control and current readout of the biosensors. A mixed-signal circuit block generates sub-Hertz triangular waveform for the biosensors by means of a direct-digital-synthesizer to control CV. A current to pulse-width converter is realized to output the data for CA measurement. The IC is fabricated in 0.18 μm technology. It consumes 220 μW from 1.8 V supply voltage, making it suitable for remotely-powered applications. Electrical measurements show excellent linearity in sub- μA current range. Electrochemical measurements including CA measurements of glucose and lactate and CV measurements of the anti-cancer drug Etoposide have been acquired with the fabricated IC and compared with a commercial equipment. The results obtained with the fabricated IC are in good agreement with those of the commercial equipment for both CV and CA measurements.
- 9 May 2014
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 14 (6) , 3180-3184
High-Performance Multipanel Biosensors Based on a Selective Integration of Nanographite Petals
We report the first selective growth of nanographite petals and various carbon nanomaterials onto a multipanel electrochemical platform. Different types of nanomaterials can be obtained by fine-tuning the growth parameters of the chemical vapor deposition (CVD) process. First, absolute novelty is the catalytic CVD selective growth of different carbon nanomaterials only on the working electrodes of the platform. A second novelty is the growth obtained at complementary metal-oxide-semiconductor compatible temperatures. These novel electrodes have been incorporated in sensors in which performance characteristics improve with the content of nanostructures. Unprecedented sensing parameters with respect to both direct and enzyme-mediated electrochemical biodetection have been obtained.
- 9 May 2014
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 14 (6) , 3180-3184
High-Performance Multipanel Biosensors Based on a Selective Integration of Nanographite Petals
We report the first selective growth of nanographite petals and various carbon nanomaterials onto a multipanel electrochemical platform. Different types of nanomaterials can be obtained by fine-tuning the growth parameters of the chemical vapor deposition (CVD) process. First, absolute novelty is the catalytic CVD selective growth of different carbon nanomaterials only on the working electrodes of the platform. A second novelty is the growth obtained at complementary metal-oxide-semiconductor compatible temperatures. These novel electrodes have been incorporated in sensors in which performance characteristics improve with the content of nanostructures. Unprecedented sensing parameters with respect to both direct and enzyme-mediated electrochemical biodetection have been obtained.
- 1 March 2014
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 53, 283-287
Continuous monitoring of Naproxen by a cytochrome P450-based electrochemical sensor
- 1 March 2014
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 53, 283-287
Continuous monitoring of Naproxen by a cytochrome P450-based electrochemical sensor
- 4 December 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 13 (3) , 1018-1024
Remote System for Monitoring Animal Models With Single-Metabolite Bio-Nano-Sensors
A novel system for remote monitoring of metabolism in an animal model is proposed in this paper. The system is obtained by integrating bio-nano-sensors to detect single-metabolites, an electrochemical front-end made with off-the-shelf components, a radio frequency communication sub-system, and an antenna of new design. The system has been calibrated and tested for continuous monitoring of four different metabolites: glucose, lactate, glutamate, and adenosine triphosphate. Tests using animal models (mice) have been conducted to investigate tissue inflammation induced by the implanted bio-nano-sensors. These tests confirm that our system is suitable and reliable for remote monitoring of single-metabolites in experiments with animal models.
- 4 December 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 13 (3) , 1018-1024
Remote System for Monitoring Animal Models With Single-Metabolite Bio-Nano-Sensors
A novel system for remote monitoring of metabolism in an animal model is proposed in this paper. The system is obtained by integrating bio-nano-sensors to detect single-metabolites, an electrochemical front-end made with off-the-shelf components, a radio frequency communication sub-system, and an antenna of new design. The system has been calibrated and tested for continuous monitoring of four different metabolites: glucose, lactate, glutamate, and adenosine triphosphate. Tests using animal models (mice) have been conducted to investigate tissue inflammation induced by the implanted bio-nano-sensors. These tests confirm that our system is suitable and reliable for remote monitoring of single-metabolites in experiments with animal models.
- 1 November 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21634025,p. 124-127
Design, fabrication, and test of a sensor array for perspective biosensing in chronic pathologies
Biosensing for chronic pathologies requires the simultaneous monitoring of different parameters such as drug concentrations, inflammation status, temperature and pH. In this paper we discuss the design, fabrication and test of a sensor array hosting five biosensor platforms, a pH electrode and a temperature sensor. Different and reproducible nano-bio-functionalization can be obtained with high spatial resolution via selective electrodeposition of chitosan/MWCNT/enzyme solutions at the various electrodes. The array, completely fabricated with biocompatible materials, can be integrated with a CMOS integrated circuit and a remote powering coil for the realization of a fully implantable device.
- 1 November 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21634025,p. 124-127
Design, fabrication, and test of a sensor array for perspective biosensing in chronic pathologies
Biosensing for chronic pathologies requires the simultaneous monitoring of different parameters such as drug concentrations, inflammation status, temperature and pH. In this paper we discuss the design, fabrication and test of a sensor array hosting five biosensor platforms, a pH electrode and a temperature sensor. Different and reproducible nano-bio-functionalization can be obtained with high spatial resolution via selective electrodeposition of chitosan/MWCNT/enzyme solutions at the various electrodes. The array, completely fabricated with biocompatible materials, can be integrated with a CMOS integrated circuit and a remote powering coil for the realization of a fully implantable device.
- 1 October 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Developing highly-integrated subcutaneous biochips for remote monitoring of human metabolism
A highly integrated system for remote monitoring of several human metabolites is proposed. It is obtained by integrating several components, such as: bio-probes, carbon nanotubes, micro-fabricated gold-electrodes, temperature and pH sensors, extremely small CMOS IC and multilayer coil for remote powering data acquisition and transmission. The entire system has final sizes of only 2.2 mm in width and thick and it is long 1.5 cm. In this paper, results on sensors micro-fabrication, sensing tests, IC design, and power transmission are presented. These results confirmed that the proposed approach is suitable for minimally invasive monitoring of multi-metabolites in humans.
- 1 October 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Developing highly-integrated subcutaneous biochips for remote monitoring of human metabolism
A highly integrated system for remote monitoring of several human metabolites is proposed. It is obtained by integrating several components, such as: bio-probes, carbon nanotubes, micro-fabricated gold-electrodes, temperature and pH sensors, extremely small CMOS IC and multilayer coil for remote powering data acquisition and transmission. The entire system has final sizes of only 2.2 mm in width and thick and it is long 1.5 cm. In this paper, results on sensors micro-fabrication, sensing tests, IC design, and power transmission are presented. These results confirmed that the proposed approach is suitable for minimally invasive monitoring of multi-metabolites in humans.
- Open Access
Fully Integrated Biochip Platforms for Advanced Healthcare
Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications.
Open AccessFully Integrated Biochip Platforms for Advanced Healthcare
Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications.